What Can You Expect at the Premier European Bispecific Forum in 2026?

A Pivotal Moment for Bispecific & Multispecific Antibodies
European pipelines are accelerating, biopharma investment is intensifying, and next‑generation engineering is unlocking increasingly precise, multi‑targeted therapies with real clinical potential.

As this momentum expands beyond oncology into autoimmunity and immunology, bispecific, trispecific, and multispecific antibodies are emerging as powerful modalities capable of redefining treatment paradigms.

Download the Agenda
2 (1)

Content Covered

Over three days, the summit brings together senior leaders from antibody engineering, translational science, and preclinical development to discuss the decisions, trade‑offs, and lessons shaping next‑generation multispecific pipelines. Across 3 days, you will:

Discover the Latest Advances in Multispecific Design

Explore cutting‑edge developments in antibody engineering, T‑cell engagers, and bispecific ADCs. Benchmark your approach against emerging innovation and strengthen pipeline decision‑making.

Gain Data‑Backed Strategies to Expand the Therapeutic Window

Learn how leading teams are optimising potency while reducing toxicity risk, enabling safer progression toward IND and early clinical milestones.

Access In‑Depth Case Studies Across Oncology & Autoimmunity

Understand what’s working in translation, where programmes derail, and how teams are mitigating risk across diverse disease settings.

Build High‑Value Partnerships Across Europe’s Ecosystem

Connect with senior pharma and biotech innovators to accelerate collaboration, de‑risk development, and unlock new strategic opportunities.

Unmissable Event Highlights for 2026:

De-Risk Bispecific, T-Cell Engager & Bispecific ADC Development from Concept to Clinic

Learn how leading biopharma teams are reducing toxicity, improving translation, and accelerating clinical progress
Insights from: Roche, Sanofi and AstraZeneca

Unlock Solid Tumour Success with Next-Generation Bispecifics

Explore innovative formats and targeting strategies designed to overcome historical efficacy and delivery challenges
Insights from: Philochem, Adaptam Therapeutics, Molecular Partners, Enara Bio & more

Design Safer, More Potent Immune-Engaging Therapies

Understand how smarter engineering and logic-gated approaches can expand the therapeutic window
Insights from: Genmab, LabGenius and Biomunex Pharmaceuticals

Stay Ahead of Emerging Targets, Modalities & Multispecific Innovation

Gain early insight into the next wave of bispecific, trispecific, and multispecific strategies shaping future pipelines
Insights from: UCB, Valink Therapeutics, NovelGen and Light Chain Bioscience

Explore the Full Event Guide

  • Hear from 25+ world-class speakers across pharma and biotech sharing cutting-edge data on bispecific antibodies, T-cell engagers, and next-generation multispecific formats advancing toward clinical success
  • Connect with 60+ senior attendees driving innovation in solid tumour targeting, immune cell redirection, and next-generation engineering strategies
  • Gain insights from 20+ data-driven presentations covering translational challenges, safety optimisation, potency enhancement and strategies to improve clinical durability
  • Take part in a dedicated Scientific Poster Session, spotlighting novel targets, platform technologies, and preclinical-to-clinical translation data
  • Unlock 7+ hours of high-value networking, designed to foster strategic collaborations, partnerships, and pipeline acceleration
Download the Agenda
Brochure Cover Templates

Attending Companies Include

Load More
CB-CDx-0690-min-scaled11[1]

Explore the Agenda

Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.

View Presentations & Speakers
CB-CDx-0330-min-scaled11[1]

Partner With Us

Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.

Explore Sponsorship Options
Join-Biopharma-Experts11[1]

Join Biopharma Experts

Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.

Register Now